Trending
Recently Published
Here's what the Artemis 2 astronauts will be doing on each day of NASA's historic moon mission31.03.2026The crew's 10-day mission will be filled with science, spacecraft tests, medical checks, survival training and more.
Picking the Right Home Machines: A Commonsense Aide05.06.2024Picking the right domestic devices can incredibly upgrade your home's usefulness and solace. With the wide assortment of apparatuses accessible
Experience Arranging: Planning for Epic Excursions01.01.1Presentation:\nLeaving on an incredible experience is a thrilling encounter that offers the opportunity to investigate new skylines, challenge your cutoff points, and make enduring recollections. Whether it's a cross-coun
IDF strikes Shiraz petrochemical site, releases footage of attacks on Iranian air defenses07.04.2026Israel said the targeted Shiraz facility produced key missile-related chemical components, while new military footage showed strikes on Iranian air defense systems. The IDF hit a petrochemical compound in Shiraz on Monday, the military announced on Tuesday, stating that the facility was "one of the last remaining sites used for producing critical chemical components for explosives and other materials for developing ballistic missiles.
In these U.S. groups, deaths now exceed births. What’s happening?24.11.2025Q: What are the demographics of birth and death? - N. Kabugu in Texas A: Great question, Mr. Kabugu! Unlike much of Europe and East Asia, America hasn’t reached the point at which we have more people dying than we do being born.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. At least not in the long run. We briefly blew past that point in a few winter months at the height of the covid-19 pandemic, according to our analysis of birth-
Nestlé recalls infant formula in 49 countries. See list.09.01.2026The recall affects nearly 50 countries across the globe. The infant formula was recalled after it may have been contaminated with a toxin.
Pfizer says patient dies after receiving hemophilia drug in trial23.12.2025Dec 23 () - A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said. The individual died on December 14 after suffering a stroke followed by a brain hemorrhage, according to the European Haemophilia Consortium, a patient support group.
Thousands of ultra-orthodox protest in Jerusalem against conscription06.01.2026Thousands of ultra-Orthodox individuals have demonstrated against their conscription into the Israeli military, according to media reports. Leading rabbis called for the protest in Jerusalem, the Times of Israel reported on Tuesday.











